Skip to content

Study to evaluate clinical effects of Polymyxins and Ceftazidime-Avibactum in critical patients and evaluate which group has better outcomes (CoP CAcRE)

Clinical outcomes of Ceftazidime-Avibactam Versus Polymyxins in Critically ill Patients With Carbapenem Resistant Enterobacteraceae Infections in Tertiary Care Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058761
Enrollment
60
Registered
2023-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Research institution
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Critically ill patients admitted in ICU with features of Sepsis 2.Microbiological culture confirmed CRE infection (Pulmonary and Blood stream) 3.Patients who have received CAZ/AVI or Polymyxins for at least 72 hours

Exclusion criteria

Exclusion criteria: 1.Polymicrobial cultures 2.Patients who have already received CAZ/AVI or Polymyxins before ICU admission 3.Patients with CKD 4.Patients with chemotherapy or immunosuppressant therapy in last three months • Post organ transplant patients

Design outcomes

Primary

MeasureTime frame
To determine and compare Clinical success rate between two groups of patients Timepoint: 14 days

Secondary

MeasureTime frame
1.To determine & compare length of ICU stay between two groups of patients 2. To determine and compare bacteriological clearance within 72 hours of antibiotic initiation 3. Evaluation of side effects between two groups Timepoint: 72 hours 14 days

Countries

India

Contacts

Public ContactNeha Bhardwaj

Army Hospital, Research and Referral

dhawanmanish2000@yahoo.com9535360243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026